Custom Search

Our Products · On-Line Store

monilia250.jpg (13573 bytes)

yeast250.jpg (19172 bytes)

Yeast250.jpg (8956 bytes)

 

Yeast Infections

Vaginal yeast infections are common, monilial overgrowths in the vagina and vulvar areas, characterized by itching,dryness, and a thick, cottage-cheese appearing vaginal discharge. The vulva may be reddened and irritated to the point of tenderness.

These infections are particularly troublesome in operational settings where they are both frequent and annoying. Yeast thrives in damp, hot environments and women in such circumstances are predisposed toward these infections.Women who take broad-spectrum antibiotics are also predisposed towards these infections because of loss of the normal vaginal bacterial flora.

Yeast organisms are normally present in most vaginas, but in small numbers. A yeast infection, then, is not merely the presence of yeast, but the concentration of yeast in such large numbers as to cause the typical symptoms of itching, burning and discharge. Likewise, a "cure" doesn't mean eradication of all yeast organisms from the vagina. Even if eradicated, they would soon be back because that is where they normally live. A cure means that the concentration of yeast has been restored to normal and symptoms have resolved.

The diagnosis is often made by history alone, and enhanced by the classical appearance of a dry, cheesy vaginal discharge. It can be confirmed by microscopic visualization of clusters of thread-like, branching Monilia organisms when the discharge is mixed with KOH.

Treatment consists of an oral antifungal agent,

  • Fluconazole 150 mg oral tablet, one tablet in single dose,

or intravaginal agents:

  • Butoconazole 2% cream 5 g intravaginally for 3 days
  • Clotrimazole 1% cream 5 g intravaginally for 7-14 days
  • Clotrimazole 100 mg vaginal tablet for 7 days
  • Clotrimazole 100 mg vaginal tablet, two tablets for 3 days
  • Clotrimazole 500 mg vaginal tablet, one tablet in a single application
  • Miconazole 2% cream 5 g intravaginally for 7 days
  • Miconazole 200 mg vaginal suppository, one suppository for 3 days
  • Miconazole 100 mg vaginal suppository, one suppository for 7 days
  • Nystatin 100,000-unit vaginal tablet, one tablet for 14 days
  • Tioconazole 6.5% ointment 5 g intravaginally in a single application
  • Terconazole 0.4% cream 5 g intravaginally for 7 days
  • Terconazole 0.8% cream 5 g intravaginally for 3 days
  • Terconazole 80 mg vaginal suppository, one suppository for 3 days.

If none of these products are available, douching with a weak acid solution (2 teaspoons of vinegar in a quart of warm water) twice a day will help restore an acid pH to the vagina, inhibiting yeast proliferation. Stop douching when symptoms have resolved as the douche itself tends to remove some of the protective mucous within the vagina.

Whenever the skin of the vulva is involved, more frequent treatment for a longer period of time may be necessary.

Reoccurrences are common and can be treated the same as for initial infections. For chronic recurrences, many patients find the use of a single applicator of Monistat 7 at the onset of itching will abort the attack completely. Sexual partners need not be treated unless they are symptomatic.

CDC Treatment Guidelines

Note to readers from the Brookside Associates:
Although this page faithfully reproduces the original Operational Medicine 2001, there are  newer CDC Treatment Guidelines (2006) available here.

 

Note to readers from the Brookside Associates:
Operational Obstetrics & Gynecology was released in 2000. There is a newer product, Military Obstetrics & Gynecology available here.

 

These videos are enhancements to the original Department of the Navy Publication, provided by the Brookside Associates Medical Education Division

Pelvic Exam Video

Vulva Anatomy Video

Wet Mount Video

 

Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300

Operational Obstetrics & Gynecology - 2nd Edition
The Health Care of Women in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMEDPUB 6300-2C
January 1, 2000


 

 

Approved for public release; Distribution is unlimited.
The listing of any non-Federal product in this CD is not an endorsement of the product itself, but simply an acknowledgement of the source. 

Bureau of Medicine and Surgery
Department of the Navy
2300 E Street NW
Washington, D.C
20372-5300

Operational Medicine
 Health Care in Military Settings
CAPT Michael John Hughey, MC, USNR
NAVMED P-5139
  January 1, 2001

United States Special Operations Command
7701 Tampa Point Blvd.
MacDill AFB, Florida
33621-5323

*This web version is provided by The Brookside Associates Medical Education Division.  It contains original contents from the official US Navy NAVMED P-5139, but has been reformatted for web access and includes advertising and links that were not present in the original version. This web version has not been approved by the Department of the Navy or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. The Brookside Associates is a private organization, not affiliated with the United States Department of Defense.

Contact Us  ·  Other Brookside Products

Operational Medicine 2001
Contents

 

 

 

Advertise on this site